Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae

Tumbarello, Mario; Maria Trecarichi, Enrico; Corona, Alberto; Giuseppe De Rosa, Francesco; Bassetti, Matteo; Mussini, Cristina; Menichetti, Francesco; Viscoli, Claudio; Campoli, Caterina; Venditti, Mario; De Gasperi, Andrea; Mularoni, Alessandra; Tascini, Carlo; Parruti, Giustino; Pallotto, Carlo; Sica, Simona; Concia, Ercole; Cultrera, Rosario; De Pascale, Gennaro; Capone, Alessandro; Antinori, Spinello; Corcione, Silvia; Righi, Elda; Raffaella Losito, Angela; Digaetano, Margherita; Amadori, Francesco; Roberto Giacobbe, Daniele; Ceccarelli, Giancarlo; Mazza, E.; Raffaelli, Francesca; Spanu, Teresa; Cauda, Roberto; Viale, Pierluigi

doi:10.1093/cid/ciy492

Public

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae

Published in Clinical Infectious Diseases • Jun 6, 2018

Authors:

Mario Tumbarello

Enrico Maria Trecarichi

Alberto Corona

Abstract

Background: Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the treatment of complicated intra-abdominal and urinary tract infections, as well as hospital-acquired pneumonia, and for gram-negative infections with limited treatment options. CAZ-AVI displays in vitro activity against K...

Subject

Ceftazidime/avibactam

Medicine

Bacteremia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!